Conclusions on biologics in rehabilitation research and clinical care.

作者信息

Wagner Amy K

机构信息

Department of Physical Medicine and Rehabilitation, University of Pittsburgh, 3471 Fifth Ave, Suite 202, Pittsburgh, PA 15213, USA.

出版信息

PM R. 2011 Jun;3(6 Suppl 1):S158. doi: 10.1016/j.pmrj.2011.05.008.

DOI:10.1016/j.pmrj.2011.05.008

PMID:21703574

Abstract

摘要

相似文献

Conclusions on biologics in rehabilitation research and clinical care.

PM R. 2011 Jun;3(6 Suppl 1):S158. doi: 10.1016/j.pmrj.2011.05.008.

Setting the research agenda for future clinical trials on the use of biologics in rheumatology.

Rheumatology (Oxford). 2011 Aug;50(8):1356-7. doi: 10.1093/rheumatology/keq370. Epub 2010 Nov 30.

Rehabilomics: a conceptual framework to drive biologics research.

PM R. 2011 Jun;3(6 Suppl 1):S28-30. doi: 10.1016/j.pmrj.2011.04.013.

Advancing rehabilitation research: an interactionist perspective to guide question and design.

Disabil Rehabil. 2006 Oct 15;28(19):1169-76. doi: 10.1080/09638280600551567.

Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.

PM R. 2011 Jun;3(6 Suppl 1):S139-47. doi: 10.1016/j.pmrj.2011.02.012.

Health care delivery science.

Spine (Phila Pa 1976). 2011 Mar 15;36(6):417-8. doi: 10.1097/BRS.0b013e31820ff2d7.

Delivery of primary care to the physically challenged.

Arch Phys Med Rehabil. 1993 Dec;74(12 Spec No):S15-9.

Characteristics of assistive technology service delivery models: stakeholder perspectives and preferences.

Disabil Rehabil. 2005 Dec 30;27(24):1461-70. doi: 10.1080/09638280500264535.

Competing Risks: Investing in Sickness Rather Than Health.

Am J Prev Med. 2016 May;50(5 Suppl 1):S45-S50. doi: 10.1016/j.amepre.2015.12.005.

Strengthening health systems to provide rehabilitation services.

Bull World Health Organ. 2017 Mar 1;95(3):167. doi: 10.2471/BLT.17.191809.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Conclusions on biologics in rehabilitation research and clinical care.

PM R. 2011 Jun;3(6 Suppl 1):S158. doi: 10.1016/j.pmrj.2011.05.008.

Setting the research agenda for future clinical trials on the use of biologics in rheumatology.

Rheumatology (Oxford). 2011 Aug;50(8):1356-7. doi: 10.1093/rheumatology/keq370. Epub 2010 Nov 30.

Rehabilomics: a conceptual framework to drive biologics research.

PM R. 2011 Jun;3(6 Suppl 1):S28-30. doi: 10.1016/j.pmrj.2011.04.013.

Advancing rehabilitation research: an interactionist perspective to guide question and design.

Disabil Rehabil. 2006 Oct 15;28(19):1169-76. doi: 10.1080/09638280600551567.

Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.

PM R. 2011 Jun;3(6 Suppl 1):S139-47. doi: 10.1016/j.pmrj.2011.02.012.

Health care delivery science.

Spine (Phila Pa 1976). 2011 Mar 15;36(6):417-8. doi: 10.1097/BRS.0b013e31820ff2d7.

Delivery of primary care to the physically challenged.

Arch Phys Med Rehabil. 1993 Dec;74(12 Spec No):S15-9.

Characteristics of assistive technology service delivery models: stakeholder perspectives and preferences.

Disabil Rehabil. 2005 Dec 30;27(24):1461-70. doi: 10.1080/09638280500264535.

Competing Risks: Investing in Sickness Rather Than Health.

Am J Prev Med. 2016 May;50(5 Suppl 1):S45-S50. doi: 10.1016/j.amepre.2015.12.005.

Strengthening health systems to provide rehabilitation services.

Bull World Health Organ. 2017 Mar 1;95(3):167. doi: 10.2471/BLT.17.191809.